SCHEMBL260759

SCHEMBL260759

CC(C(=O)O)n1c(=O)n2c3c(c(Cl)ccc31)NC(=O)C2

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PTGDR2 Q9Y5Y4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2028810 1.00 PTGDR2 (0.32) PTGDR2
SCHEMBL259895 0.78 CALCRL (0.42) —
SCHEMBL260186 0.75 — —
SCHEMBL259828 0.66 CALCRL (0.42) —
SCHEMBL12580792 0.63 AHR (0.36) —
SCHEMBL18180382 0.62 KMT2A (0.45) —
SCHEMBL3104074 0.61 NOTUM (0.44) PTGDR2
SCHEMBL11397353 0.59 ALDH1A1 (0.41) PTGDR2
SCHEMBL7862920 0.59 ALDH1A1 (0.42) —
SCHEMBL7336986 0.57 KDM4E (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163752-B2 Tricyclic anilide heterocyclic CGRP receptor antagonists Merck, Sharp & Dohme Corp. (US) 2012-04-24 — — US disclosed
US-8133891-B2 Tricyclic anilide spirolactam CGRP receptor antagonists Merck, Sharp & Dohme Corp. (US) 2012-03-13 — — US disclosed
EP-1794146-B1 TRICYCLIC ANILIDE SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME (US) 2011-08-03 — — EP disclosed
US-7968540-B2 Spirohydantoin tricyclic CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2011-06-28 — — US disclosed
US-7947677-B2 Spirolactam tricyclic CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2011-05-24 — — US disclosed
Send feedback